Viewing data from:

NITROGLYCERIN

ANDA

NITROGLYCERIN | A091496 | PADAGIS ISRAEL PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: NITROLINGUAL PUMPSPRAY(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$24.03

per gm

Lowest NADAC/Unit

$17.15

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45802021001NITROGLYCERIN 400 MCG SPRAY	$24.03	GM	Generic	—	2026-06-17
45802021002NITROGLYCERIN 400 MCG SPRAY	$17.15	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$43.23

Highest Price

$61.15

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
45802-0210-01NITROGLYCERIN 0.4MG/SPRAY AEROSOL	$43.23	FSS	Padagis Sourcing Solutions LLC	09/30/2026
45802-0210-02NITROGLYCERIN 0.4MG/SPRAY AEROSOL	$61.15	FSS	Padagis Sourcing Solutions LLC	09/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

DYNAMIT NOBEL GMBH EXPLOSIVSTOFF UND SYSTEMTECHNIKNITROGLYCERIN

DMF 85241990

COPPERHEAD INVESTMENTS INCNITROGLYCERIN

DMF 115951995

BHARAT PHARMA (A UNIT OF BHARAT EXPLOSIVES LTD)NITROGLYCERIN AS IN DILUTED NITROGLYCERIN, USP

DMF 224352009

VICTOR M HERMELIN CO DIV K-V PHARMACAL COInactiveNITROGLYCERIN

DMF 9781966

ELI LILLY AND COInactiveNITROGLYCERIN AMPOULES

DMF 19231972

SOCIETE SUISSE DES EXPLOSIFSInactiveNITROGLYCERIN,PENTAERYTHRITOL TETRANITRATE AND ISOSORBIDE DINITRATE

DMF 45041982

DYNAMIT NOBEL AGInactiveNITROGLYCERIN 5% IN MIGLYOL 829

DMF 68471987

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 24, 2013	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.4MG/SPRAY

0 patents0 exclusivities▴

SPRAY, METERED;SUBLINGUAL | Approved: Sep 20, 2013

No patent or exclusivity listings for this strength.